Literature DB >> 2464589

Structure and function relationship of Pseudomonas exotoxin A. An immunochemical study.

J Hwang1, M S Chen.   

Abstract

We have raised antisera against Pseudomonas exotoxin A (PE) and domains Ia and III to study the structure-function relationships of PE. Anti-PE antibody (AbPE) was shown to abolish the ADP-ribosylation activity of PE. However, neither antidomain Ia antibody nor antidomain III antibody inhibited the ADP-ribosylation activity of PE. This suggests that the inhibition of ADP-ribosylation by AbPE results from the binding of AbPE to the region between domains Ia and III. Since the binding of AbPE to PE did not inhibit NAD hydrolysis in the absence of elongation factor 2, the inhibitory effect of AbPE on ADP-ribosylation may be due to steric hindrance rather than a direct action on the catalytic function. Thus, the interface between domain Ia and III may be the site of entry of elongation factor 2 during ADP-ribosylation. The antibodies were also used to study both the inhibitory effects of PE on protein synthesis and its cytotoxic activity. Either AbPE or antidomain Ia antibody, but not antidomain III antibody, was able to reverse the inhibition of protein synthesis by PE and to block its cytotoxicity. In addition, rabbits immunized with domain Ia acquired tolerance against 100 micrograms of PE injected subcutaneously. These results suggest that domain Ia is the cell-binding domain of PE and may be used for vaccination against PE-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464589

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  5 in total

1.  Lipid interaction of Pseudomonas aeruginosa exotoxin A. Acid-triggered permeabilization and aggregation of lipid vesicles.

Authors:  G Menestrina; C Pederzolli; S Forti; F Gambale
Journal:  Biophys J       Date:  1991-12       Impact factor: 3.699

2.  Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.

Authors:  K Rutault; M J Vacheron; M Guinand; G Michel
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.609

3.  Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A.

Authors:  H F Shang; M L Yeh; C P Lin; J Hwang
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  Binding of monoclonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH 4 strongly neutralizes exotoxin A-induced cytotoxicity in cell culture and in vivo.

Authors:  H Ohtsuka; K Horigome; A Higuchi; N Nomura; H Ochi; S Yokota; T Kohzuki; H Noguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.609

5.  A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.

Authors:  C W Liao; T H Hseu; J Hwang
Journal:  Appl Microbiol Biotechnol       Date:  1995-07       Impact factor: 5.560

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.